Getting discovered the palmitoylation motif of APLNR, we designed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the development of NCP, including pain incidence, microglial activation, and inflammatory factor release https://can-conolidine-help-with32086.blog5.net/68407133/about-block-pain-receptors-with-proleviate